SCA practice case · Video consultation
“I don’t want to put steroids on my baby — won’t they thin her skin?”
Video consultation
Child patient
Someone else speaking
Typical
Children & young peopleLong-term conditions & cancer
The candidate brief
This is what you would read in the 3-minute window before the patient connects. Read it once, note two or three hypotheses and one thing you must not miss, then stop.
Patient
Anaya Sandhu · 2 years · female
Setting
Video consultation — a flaring atopic eczema (mother present).
Past history
- Atopic eczema
Medication
- Topical corticosteroid (issued, not used)
- Emollient
Allergies
None recorded
Recent notes
Current flare of eczema. Steroid issued previously; mother declined to use it.
Reason for contact
Mother booked: "Her eczema is really bad again and none of us are sleeping."
Practise this case
The full case is in the Hot Seat with the Gold plan. You get a 12-minute timer, a role-player script with facts released only when asked, examiner checkpoints by the three RCGP domains, a model consultation and the guidance behind it.
What this case tests
Show the learning points (spoiler: read after you have practised)
An atopic eczema flare with topical-steroid phobia is, above all, an adherence and trust problem. Assess the flare and its impact — extent, itch and especially sleep disturbance (a key severity/family-impact marker) — and check for infection (bacterial weeping/golden crusting; eczema herpeticum, with clustered punched-out vesicles, rapid worsening or an unwell child, which is urgent). Steroid phobia is extremely common and drives under-treatment, so do not dismiss it: validate it as understandable given conflicting online information, then correct it with accurate facts — topical steroids used correctly (potency matched to site and severity, short bursts to control flares) are safe and effective; skin thinning is associated with prolonged use of potent steroids on inappropriate sites rather than appropriate short courses; and under-treating eczema from steroid fear prolongs the child’s itch, sleeplessness, infection risk and suffering, so the fear itself causes harm. Establish emollients as the cornerstone (generous, frequent, used as a soap substitute, continued even when clear, prescribed in large quantities — children commonly need 250–500 g a week, NICE CG57) and explain correct steroid use (NICE CG57 potency by site: mild for face and neck, moderate or potent for only 7–14 days in axillae and groin; once or twice daily, NICE TA81) with the fingertip-unit guide (one FTU covers two adult hands, BAD 2024), applied to active eczema only, then stepped down. Address triggers and scratch management, recognise and treat infection (bacterial: NICE NG190, antibiotics only if needed; eczema herpeticum needs immediate systemic aciclovir and same-day referral, with face-to-face assessment of any suspected infection), and know when to escalate to dermatology, providing a written step-up/step-down plan. The hidden agenda is a protective fear born of wanting to keep the child safe, with distress at the family’s sleeplessness and helplessness beneath; respect and answer the fear rather than overriding it, build trust, and give a clear regimen she believes in — turning her into a confident treater, because adherence is the whole game in eczema.
The guidance behind it
Similar SCA cases
gpreasoning.uk is not affiliated with or endorsed by the RCGP. Our cases are original teaching material written for practice; none is an exam recall. For anything official about the SCA, check the RCGP SCA pages.